No Data
No Data
BofA Securities Maintains IGM Biosciences(IGMS.US) With Hold Rating, Announces Target Price $2.25
Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround
IGM Biosciences Analyst Ratings
BofA Securities Initiates IGM Biosciences(IGMS.US) With Hold Rating
Bank of America Securities Sticks to Their Hold Rating for IGM Biosciences (IGMS)
JPMorgan Upgrades IGM Biosciences to Neutral From Underweight